India’s multi-stage malaria vaccine
AdFalci Vax — India’s 1st indigenous multi-stage malaria vaccine 💉🌍 developed by ICMR-Regional Medical Research Centre, Bhubaneswar.
Licensed to industry partners under #PatentMitra .
Innovation ➡️ Impact.
Innovation
AdFalci Vax is a multi-stage recombinant malaria vaccine developed by ICMR – RMBC Bhubaneswar, Engineered in Lactococcus lactis and formulated with a pharmaceutically acceptable carrier.
💡 Key Highlights:
✔️ Targets parasite before bloodstream entry, preventing transmission
✔️ Affordable, stable & scalable solution
✔️ Remains effective for 9+ months at room temperature
Licensed to leading industry partners – Panacea Biotec, Biological E, Zydus Lifesciences, Indian Immunologicals, and Techinvention Lifecare.
Together, we move closer to a malaria-free future.
Explore more
🎤 Career – Real career stories and job profiles of life science professionals. Discover current opportunities for students and researchers.
💼 Jobs – The latest job openings and internship alerts across academia and industry.
📢 Advertise with BioPatrika – Reach the Right Audience, Fast!
🛠️ Services – Regulatory support, patent filing assistance, and career consulting services.
